Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study
Abstract Background Most health authorities do not recommend screening for prostate cancer with PSA tests in asymptomatic patients who are not at increased risk. However, opportunistic screening for prostate cancer is still wanted by many patients and it is widely used in primary care clinics, with...
Main Authors: | Pia Kirkegaard, Adrian Edwards, Trine Laura Overgaard Nielsen, Torben Falck Ørntoft, Karina Dalsgaard Sørensen, Michael Borre, Flemming Bro |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-02-01
|
Series: | BMC Family Practice |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12875-018-0717-6 |
Similar Items
-
A genetic risk assessment for prostate cancer influences patients’ risk perception and use of repeat PSA testing: a cross-sectional study in Danish general practice
by: Jacob Fredsøe, et al.
Published: (2020-05-01) -
Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis
by: Maibritt Nørgaard, et al.
Published: (2017-09-01) -
Prognostic DNA Methylation Markers for Prostate Cancer
by: Siri H. Strand, et al.
Published: (2014-09-01) -
The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial.
by: Jacob Fredsøe, et al.
Published: (2020-02-01) -
The LEAD trial - the effectiveness of a decision aid on decision making among citizens with lower educational attainment who have not participated in FIT-based colorectal cancer screening in Denmark: study protocol for a randomized controlled trial
by: Pernille Gabel, et al.
Published: (2018-10-01)